Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by SamV21on Mar 20, 2022 6:24pm
112 Views
Post# 34530031

RE:RE:QIXLEEF™ MIGHT be an effective analgesic for pain management

RE:RE:QIXLEEF™ MIGHT be an effective analgesic for pain managementSelling off at .07 to buy back in at .04 is my guess or getting what they can before it halts.Pumpers can't  or don't even read the news releases before the pom poms come out.Might be,could be read these news releases. No results , no buyout, nothing except more repeat old news with a new date posted.

Old news releases from Tetra web page .

OTTAWA, Oct. 03, 2019
The Phase 3 Serenity® trial for advanced cancer pain is currently recruiting patients at 20 clinical trial sites across the United States and Canada. Tetra continues to anticipate regulatory approval for CAUMZ by late 2020.
Yup right on time like the CEO said ! 

ORLEANS, Ontario, Dec. 03, 2018
Guy Chamberland, President and CEO of Tetra Bio-Pharma stated, "With its Hemp Energy Drink business, Tetra Natural Health will allow the corporation to achieve significant orders and sales over the coming year.  These orders demonstrate that the new team has established a viable natural health and wellness product business that will translate into significant revenues for the coming fiscal year, starting in Q1 2019."
What ? it was sold off ? we bought shares thinking we were going to have revenue ? the CEO said !!! 
And you wonder why shareholders don't want to hear any more pumping on nothing from know nothing pumping posts !!!!! and call you out on fake news and false information . Until results are released from Health Canada or the FDA its all typical GUY keep shareholders by the phone garbage, its sink or swim time for the CEO vet. I guess one should never trust or send a Vet to do a Drs. job ! because he really has no clue as to what is involved in getting results or revenue .
<< Previous
Bullboard Posts
Next >>